PDF Biotechnology_I...pdf | Download (334kB) Available under University of Tasmania Standard License.

Abstract

The key issue is why one should be
interested in biotechnology indicators and
why we are interested in collecting them.
From the OECD point of view, we are
largely interested in them from a policy
perspective. There are also two other reasons
for collecting indicators. One is because
they are very much of interest to academics
who can use indicators to develop a longterm
or deeper understanding of how
economies are structured and how
economies can change. Second, indicators
are of interest to private investors who can
use the information to guide their
investment decisions in one particular
technology or another. But many of the
indicators for investors come too late. This
has always been a problem for us because
the investment community really wants to
know what is happening right now and by
the time our indicators are published we
are usually several years too late.
From a public policy perspective, we
are still really in the world of expectations
when we talk about biotechnology,
particularly modern biotechnology. I think
we are all familiar with these type of
expectations, and variations of them show
up in many difFerent reports from all around
the world. The problem with biotech is that
many of these expectations have not yet
been realized except in very small ways.

Item Type:	Report (Technical Report)
Authors/Creators:	Arundel, A
Publisher:	OECD
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page